|
ZIP4 is a Novel Molecular Target in Human Pancreatic Cancer
|
5R01CA186338-04
|
$342,938
|
$342,938
|
LI, MIN
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
Yale Cancer Center NCTN
|
5U10CA180826-05
|
$700,035
|
$35,002
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Particip
|
5U10CA180864-05
|
$542,950
|
$10,859
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S1
|
$72,918
|
$3,646
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S2
|
$200,473
|
$10,024
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S3
|
$234,000
|
$11,700
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-10
|
$2,574,000
|
$128,700
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
5U10CA180833-05
|
$1,394,352
|
$69,718
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Washington University SPORE in Pancreatic Cancer
|
5P50CA196510-03
|
$2,300,000
|
$2,300,000
|
HAWKINS, WILLIAM
|
WASHINGTON UNIVERSITY
|
|
Washington University Human Tumor Atlas Research Center
|
1U2CCA233303-01
|
$1,752,191
|
$578,223
|
DING, LI
|
WASHINGTON UNIVERSITY
|
|
Video Informed Consent Tools to Improve Care for Patients With Advanced Pancreatic Cancer
|
5K07CA204201-03
|
$176,941
|
$176,941
|
ENZINGER, ANDREA
|
DANA-FARBER CANCER INST
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
5U10CA180847-06
|
$503,410
|
$25,171
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Validation of biomarkers for early diagnosis and risk prediction of pancreatic neoplasms
|
5U01CA200466-03
|
$1,563,388
|
$1,563,388
|
BRAND, RANDALL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Validation and Fine-Scale Mapping of Pancreatic Cancer Susceptibility Loci (Study)
|
5R01CA154823-07
|
$641,991
|
$641,991
|
KLEIN, ALISON
|
JOHNS HOPKINS UNIVERSITY
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
2P30CA014520-44
|
$4,590,130
|
$45,901
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S1
|
$250,000
|
$2,500
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S2
|
$136,232
|
$1,362
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S3
|
$75,711
|
$757
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S4
|
$31,772
|
$318
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Utilizing Precision Medicine to elucidate the mechanisms underpinning treatment efficacy
|
1K99CA230384-01
|
$107,860
|
$53,930
|
HOPKINS, BENJAMIN
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
5U10CA180870-05
|
$644,932
|
$8,062
|
GERBER, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
5U10CA180858-05
|
$1,267,600
|
$15,845
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Using markers to improve pancreatic cancer screening and surveillance
|
5U01CA210170-03
|
$954,328
|
$954,328
|
GOGGINS, MICHAEL
|
JOHNS HOPKINS UNIVERSITY
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-43S1
|
$40,593
|
$1,218
|
FARNHAM, PEGGY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
5P30CA014089-43
|
$6,268,475
|
$188,054
|
FARNHAM, PEGGY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-27S1
|
$247,355
|
$17,315
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-27S2
|
$35,000
|
$2,450
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-27S3
|
$124,862
|
$8,740
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-27S4
|
$48,726
|
$3,411
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-27S5
|
$174,039
|
$12,183
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-27S6
|
$107,460
|
$7,522
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of Virginia Cancer Center Support Grant
|
5P30CA044579-27
|
$2,599,349
|
$181,954
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of Texas PDX Development and Trial Center
|
3U54CA224065-01S1
|
$175,000
|
$15,750
|
ROTH, JACK
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
University of Colorado Cancer Center Support Grant
|
3P30CA046934-30S3
|
$223,326
|
$4,467
|
SCHULICK, RICHARD
|
UNIVERSITY OF COLORADO DENVER
|
|
University of Colorado Cancer Center Support Grant
|
5P30CA046934-30
|
$3,853,226
|
$77,065
|
SCHULICK, RICHARD
|
UNIVERSITY OF COLORADO DENVER
|
|
University of Colorado Cancer Center Support Grant
|
3P30CA046934-30S1
|
$39,685
|
$794
|
THEODORESCU, DAN
|
UNIVERSITY OF COLORADO DENVER
|
|
University of Colorado Cancer Center Support Grant
|
3P30CA046934-30S2
|
$243,547
|
$4,871
|
THEODORESCU, DAN
|
UNIVERSITY OF COLORADO DENVER
|
|
Understanding optimal delivery systems for cancer care
|
5R01CA174768-05
|
$380,646
|
$95,162
|
MILLER, DAVID
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Understanding metabolic pathways that support redox homeostasis in cancer
|
5F32CA213810-02
|
$59,038
|
$59,038
|
MUIR, ALEXANDER
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Understanding metabolic heterogeneity in pancreatic cancer
|
1K99CA234221-01
|
$118,607
|
$118,607
|
LAU, ALLISON
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Uncovering roles of polyunsaturated fatty acids in pancreatic cancer etiology
|
1K99CA218892-01A1
|
$120,472
|
$120,472
|
WU, LANG
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Uncovering Role of Exosomes in Regulating Pancreatic Cancer Cell Metabolism
|
5R01CA204969-02
|
$320,959
|
$320,959
|
NAGRATH, DEEPAK
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Ultrasound-enhanced drug penetration for treatment of pancreatic cancer
|
5R01CA154451-05
|
$506,176
|
$506,176
|
HWANG, JOO
|
UNIVERSITY OF WASHINGTON
|
|
Ultra-High Content Analysis (UHCA) of Single Cells in Tissue: 60+ channel immunofluorescence labeling kits and companion imaging software for everyone
|
4R44CA224994-02
|
$749,974
|
$374,987
|
NEDERLOF, MICHEL
|
QUANTITATIVE IMAGING SYSTEMS, LLC
|
|
UCLA Multifunctional Mesoporous Silica Nanoparticle Platform for Treatment of Pancreas Cancer
|
5U01CA198846-04
|
$459,169
|
$459,169
|
NEL, ANDRE
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
UCDCCC NCTN U10 Program
|
5U10CA180846-05
|
$623,007
|
$31,150
|
GANDARA, DAVID
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
UBAP2, A New Molecule in Pancreatic Cancer Progression
|
1R01CA220237-01A1
|
$331,688
|
$331,688
|
MUKHERJEE, PRIYABRATA
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
Tumor-associated Physiological Changes Arising from Ras-induced Mitochondrial Fission
|
5F31CA196329-03
|
$31,856
|
$31,856
|
NASCIMENTO, ALDO
|
UNIVERSITY OF VIRGINIA
|
|
Tumor subtypes and therapy response in pancreatic cancer
|
5R01CA199064-03
|
$591,406
|
$591,406
|
YEH, JEN JEN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Tumor priming sequences combined with novel nanoparticle drug carriers for enhanced therapeutic efficacy in pancreatic cancer: a tripartite USA/Northern Ireland/Republic of Ireland consortium
|
5R01CA198096-04
|
$429,377
|
$429,377
|
STRAUBINGER, ROBERT
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
Total relevant funding to Pancreas for this search: $182,103,222
|